GSK vs TOST · P/E 13, $103.31B cap vs P/E 161, rev $3.54B
GlaxoSmithKline PLC ADR (GSK) versus Toast Inc (TOST) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Toast Inc (TOST) is a software - infrastructure company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported TOST revenue for 2026-06-30 was $3.54B. Net income was $280.0M. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
Not investment advice. Open the GSK and TOST stock pages for the full models.
Not investment advice.